← FDA DRUG APPROVALS

FDA ANDA · ANDA214700

SITAGLIPTIN PHOSPHATE

Sponsor: DR REDDYS LABS LTD

APPLICATION
ANDA214700
TYPE
ANDA
ROUTE
FILM COATED
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

SITAGLIPTIN PHOSPHATENone (Tentative Approval)
SITAGLIPTIN PHOSPHATE 100MG · TABLET · FILM COATED
SITAGLIPTIN PHOSPHATENone (Tentative Approval)
SITAGLIPTIN PHOSPHATE 25MG · TABLET · FILM COATED
SITAGLIPTIN PHOSPHATENone (Tentative Approval)
SITAGLIPTIN PHOSPHATE 50MG · TABLET · FILM COATED

Approval history

2026-07-17UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →